{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T10:35:05Z","timestamp":1784543705496,"version":"3.55.0"},"reference-count":128,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82304870"],"award-info":[{"award-number":["82304870"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"College Students' Innovation and Entrepreneurship Training Program Project","award":["202510063002"],"award-info":[{"award-number":["202510063002"]}]},{"name":"Tianjin University of Traditional Chinese Medicine Graduate Student Research Innovation Project","award":["YJSKC-20240031"],"award-info":[{"award-number":["YJSKC-20240031"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-025-05447-0","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T09:49:23Z","timestamp":1764928163000},"page":"1117-1133","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The role of amino acid signaling in pathogenesis of chronic kidney disease"],"prefix":"10.1007","volume":"481","author":[{"given":"Siya","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruizhen","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meifang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"key":"5447_CR1","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","volume":"298","author":"J Coresh","year":"2007","unstructured":"Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van LenteLevey F AS (2007) Prevalence of chronic kidney disease in the united States. JAMA 298:2038\u20132047. https:\/\/doi.org\/10.1001\/jama.298.17.2038","journal-title":"JAMA"},{"key":"5447_CR2","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1681\/asn.2005121273","volume":"178","author":"SI Hallan","year":"2006","unstructured":"Hallan SI, Coresh J, Astor BC, Asberg A, Powe NR, Romundstad S, Hallan HA, Lydersen SHolmen J (2006) International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol 178:2275\u20132284. https:\/\/doi.org\/10.1681\/asn.2005121273","journal-title":"J Am Soc Nephrol"},{"key":"5447_CR3","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/sj.ki.5002701","volume":"734","author":"V Perkovic","year":"2008","unstructured":"Perkovic V, Cass A, Patel AA, Suriyawongpaisal P, Barzi F, Chadban S, MacMahon SNeal B (2008) High prevalence of chronic kidney disease in Thailand. Kidney Int 734:473\u2013479. https:\/\/doi.org\/10.1038\/sj.ki.5002701","journal-title":"Kidney Int"},{"key":"5447_CR4","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/s0140-6736(20)30045-3","volume":"39510225","author":"B Bikbov","year":"2020","unstructured":"Bikbov B, Purcell CA, Levey AS, Smith M, Abdoli A, Abebe M, Adebayo OM, Afarideh M, Agarwal SK, Agudelo-Botero M et al (2020) Global, regional, and National burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the global burden of disease study 2017. Lancet 39510225:709\u2013733. https:\/\/doi.org\/10.1016\/s0140-6736(20)30045-3","journal-title":"Lancet"},{"key":"5447_CR5","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.kint.2018.04.011","volume":"943","author":"Y Xie","year":"2018","unstructured":"Xie Y, Bowe B, Mokdad AH, Xian H, Yan Y, Li T, Maddukuri G, Tsai C-Y, Floyd TAl-Aly Z (2018) Analysis of the global burden of disease study highlights the global, regional, and National trends of chronic kidney disease epidemiology from 1990 to 2016. Kidney Int 943:567\u2013581. https:\/\/doi.org\/10.1016\/j.kint.2018.04.011","journal-title":"Kidney Int"},{"key":"5447_CR6","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1016\/s0140-6736(18)31694-5","volume":"39210159","author":"KJ Foreman","year":"2018","unstructured":"Foreman KJ, Marquez N, Dolgert A, Fukutaki K, Fullman N, McGaughey M, Pletcher MA, Smith AE, Tang K, Yuan C-W et al (2018) Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016\u201340 for 195 countries and territories. Lancet 39210159:2052\u20132090. https:\/\/doi.org\/10.1016\/s0140-6736(18)31694-5","journal-title":"Lancet"},{"key":"5447_CR7","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/s0140-6736(21)00519-5","volume":"39810302","author":"K Kalantar-Zadeh","year":"2021","unstructured":"Kalantar-Zadeh K, Jafar TH, Nitsch D, Neuen BLPerkovic V (2021) Chronic kidney disease. Lancet 39810302:786\u2013802. https:\/\/doi.org\/10.1016\/s0140-6736(21)00519-5","journal-title":"Lancet"},{"key":"5447_CR8","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.2337\/dc13-0387","volume":"36","author":"RA DeFronzo","year":"2013","unstructured":"DeFronzo RA, Hompesch M, Kasichayanula S, Liu X, Hong Y, Pfister M, Morrow LA, Leslie BR, Boulton DW, Ching A et al (2013) Characterization of renal glucose reabsorption in response to Dapagliflozin in healthy subjects and subjects with type 2 diabetes. Randomized Controlled Trial 36:3169\u20133176. https:\/\/doi.org\/10.2337\/dc13-0387","journal-title":"Randomized Controlled Trial"},{"key":"5447_CR9","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1186\/1475-2840-13-28","volume":"29","author":"DZ Cherney","year":"2014","unstructured":"Cherney DZ, Perkins BA, Soleymanlou N, Har R, Fagan N, Johansen OE, Woerle HJ, von Eynatten MUC, B (2014) The effect of empagliflozin on arterial stiffness and heart rate variability in subjects with uncomplicated type 1 diabetes mellitus. Clin Trial 29:1328. https:\/\/doi.org\/10.1186\/1475-2840-13-28","journal-title":"Clin Trial"},{"key":"5447_CR10","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/s0140-6736(13)60595-4","volume":"3829889","author":"RT Gansevoort","year":"2013","unstructured":"Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Jafar TH, Heerspink HJL, Mann JF, Matsushita KWen CP (2013) Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet 3829889:339\u2013352. https:\/\/doi.org\/10.1016\/s0140-6736(13)60595-4","journal-title":"Lancet"},{"key":"5447_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1523-1755.2004.00701","volume":"66","author":"NK Hollenberg","year":"2004","unstructured":"Hollenberg NK (2004) Aldosterone in the development and progression of renal injury. Review 66:1\u20139. https:\/\/doi.org\/10.1111\/j.1523-1755.2004.00701","journal-title":"Review"},{"key":"5447_CR12","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1056\/NEJMp048144","volume":"351","author":"JJEOM McMurray","year":"2004","unstructured":"McMurray JJEOM (2004) Treatment of heart failure with spironolactone\u2013trial and tribulations. Comment 351:526\u2013528. https:\/\/doi.org\/10.1056\/NEJMp048144","journal-title":"Comment"},{"key":"5447_CR13","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1681\/asn.2020010028","volume":"318","author":"GJ Ko","year":"2020","unstructured":"Ko GJ, Rhee CM, Kalantar-Zadeh KJoshi S (2020) The effects of High-Protein diets on kidney health and longevity. J Am Soc Nephrol 318:1667\u20131679. https:\/\/doi.org\/10.1681\/asn.2020010028","journal-title":"J Am Soc Nephrol"},{"key":"5447_CR14","doi-asserted-by":"publisher","unstructured":"Messa P (2022) Renal nutrition and metabolism. Nutrients 149. https:\/\/doi.org\/10.3390\/nu14091959","DOI":"10.3390\/nu14091959"},{"key":"5447_CR15","doi-asserted-by":"publisher","first-page":"S367","DOI":"10.1093\/advances\/nmz011","volume":"10","author":"H Kramer","year":"2019","unstructured":"Kramer H (2019) Diet and chronic kidney disease. Adv Nutr 10:S367\u2013S379. https:\/\/doi.org\/10.1093\/advances\/nmz011","journal-title":"Adv Nutr"},{"key":"5447_CR16","doi-asserted-by":"publisher","first-page":"1120718","DOI":"10.3389\/fphar.2023.1120718","volume":"14","author":"X Pang","year":"2023","unstructured":"Pang X, Miao Z, Dong Y, Cheng H, Xin X, Wu Y, Han M, Su Y, Yuan J, Shao Y et al (2023) Dietary methionine restriction alleviates oxidative stress and inflammatory responses in lipopolysaccharide-challenged broilers at early age. Front Pharmacol 14:1120718. https:\/\/doi.org\/10.3389\/fphar.2023.1120718","journal-title":"Front Pharmacol"},{"key":"5447_CR17","doi-asserted-by":"publisher","unstructured":"Schaap GHBH, Alferink TH, Oe PL, Donker AJ (1987) The effect of a high protein intake on renal function of patients with chronic renal insufficiency. Nephron. 471: 1\u20136. https:\/\/doi.org\/10.1159\/000184447. PMID: 3627332","DOI":"10.1159\/000184447"},{"key":"5447_CR18","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.jada.2003.12.028","volume":"1043","author":"JABV Beto","year":"2004","unstructured":"Beto JABV (2004) Medical nutrition therapy in chronic kidney failure: integrating clinical practice guidelines. J Am Diet Assoc 1043:404\u2013409. https:\/\/doi.org\/10.1016\/j.jada.2003.12.028","journal-title":"J Am Diet Assoc"},{"key":"5447_CR19","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1053\/j.akdh.2023.06.003","volume":"306","author":"JTG-OA Kelly","year":"2023","unstructured":"Kelly JTG-OA, St-Jules DE, Carrero JJ (2023) Animal protein intake and possible cardiovascular risk in people with chronic kidney disease: mechanisms and evidence. Adv Kidney Dis Health 306:480\u2013486. https:\/\/doi.org\/10.1053\/j.akdh.2023.06.003","journal-title":"Adv Kidney Dis Health"},{"key":"5447_CR20","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1056\/NEJMra1700312","volume":"37718","author":"K Kalantar-Zadeh","year":"2017","unstructured":"Kalantar-Zadeh K, Ingelfinger JRFouque D (2017) Nutritional management of chronic kidney disease. N Engl J Med 37718:1765\u20131776. https:\/\/doi.org\/10.1056\/NEJMra1700312","journal-title":"N Engl J Med"},{"key":"5447_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00726-009-0269-0","volume":"371","author":"G Wu","year":"2009","unstructured":"Wu G (2009) Amino acids: metabolism, functions, and nutrition. Amino Acids 371:1\u201317. https:\/\/doi.org\/10.1007\/s00726-009-0269-0","journal-title":"Amino Acids"},{"key":"5447_CR22","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1093\/ndt\/gft235","volume":"289","author":"N Thilly","year":"2013","unstructured":"Thilly N (2013) Low-protein diet in chronic kidney disease: from questions of effectiveness to those of feasibility. Nephrol Dialysis Transplantation 289:2203\u20132205. https:\/\/doi.org\/10.1093\/ndt\/gft235","journal-title":"Nephrol Dialysis Transplantation"},{"key":"5447_CR23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00726-015-2067-1","volume":"481","author":"Y Duan","year":"2015","unstructured":"Duan Y, Li F, Li Y, Tang Y, Kong X, Feng Z, Anthony TG, Watford M, Hou Y, Wu G et al (2015) The role of leucine and its metabolites in protein and energy metabolism. Amino Acids 481:41\u201351. https:\/\/doi.org\/10.1007\/s00726-015-2067-1","journal-title":"Amino Acids"},{"key":"5447_CR24","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.freeradbiomed.2019.09.003","volume":"145","author":"S Qiao","year":"2019","unstructured":"Qiao S, Liu R, Lv C, Miao Y, Yue M, Tao Y, Wei Z, Xia YDai Y (2019) Bergenin impedes the generation of extracellular matrix in glomerular mesangial cells and ameliorates diabetic nephropathy in mice by inhibiting oxidative stress via the mTOR\/\u03b2-TrcP\/Nrf2 pathway. Free Radic Biol Med 145:118\u2013135. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2019.09.003","journal-title":"Free Radic Biol Med"},{"key":"5447_CR25","doi-asserted-by":"publisher","unstructured":"Nie C, He T, Zhang W, Zhang GMa X (2018) Branched chain amino acids: beyond nutrition metabolism. Int J Mol Sci 194. https:\/\/doi.org\/10.3390\/ijms19040954","DOI":"10.3390\/ijms19040954"},{"key":"5447_CR26","doi-asserted-by":"publisher","unstructured":"Zhang C, Huang H, Li C, Wei L, Wu J, Wang R, Huang S, Chen Q, Mo P, Yin Y et al (2024) Transcriptomics and UHPLC-QQQ-MS analyses reveal the dysregulation of branched chain amino acids metabolism in renal fibrotic rats. J Pharm Biomed Anal 245. https:\/\/doi.org\/10.1016\/j.jpba.2024.116197","DOI":"10.1016\/j.jpba.2024.116197"},{"key":"5447_CR27","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/iub.1150","volume":"654","author":"A Flydal MIMartinez","year":"2013","unstructured":"Flydal MIMartinez A (2013) Phenylalanine hydroxylase: Function, structure, and regulation. IUBMB Life 654:341\u2013349. https:\/\/doi.org\/10.1002\/iub.1150","journal-title":"IUBMB Life"},{"key":"5447_CR28","doi-asserted-by":"publisher","unstructured":"Stroup BM, Murali SG, Schwahn DJ, Sawin EA, Lankey EM, B\u00e4chinger HPNey DM (2019) Sex effects of dietary protein source and acid load on renal and bone status in the Pahenu 2 mouse model of phenylketonuria. Physiological Rep 720. https:\/\/doi.org\/10.14814\/phy2.14251","DOI":"10.14814\/phy2.14251"},{"key":"5447_CR29","doi-asserted-by":"publisher","unstructured":"Belanger AM, Przybylska M, Gefteas E, Furgerson M, Geller S, Kloss A, Cheng SH, Zhu YYew NS (2018) Inhibiting neutral amino acid transport for the treatment of phenylketonuria. JCI Insight 314. https:\/\/doi.org\/10.1172\/jci.insight.121762","DOI":"10.1172\/jci.insight.121762"},{"key":"5447_CR30","doi-asserted-by":"publisher","unstructured":"Hsu C-NT Y-L (2020) Developmental programming and reprogramming of hypertension and kidney disease: impact of Tryptophan metabolism. Int J Mol Sci 2122. https:\/\/doi.org\/10.3390\/ijms21228705","DOI":"10.3390\/ijms21228705"},{"key":"5447_CR31","doi-asserted-by":"publisher","unstructured":"Chen D-Q, Cao G, Chen H, Argyopoulos CP, Yu H, Su W, Chen L, Samuels DC, Zhuang S, Bayliss GP et al (2019) Identification of serum metabolites associating with chronic kidney disease progression and anti-fibrotic effect of 5-methoxytryptophan. Nat Commun 101. https:\/\/doi.org\/10.1038\/s41467-019-09329-0","DOI":"10.1038\/s41467-019-09329-0"},{"key":"5447_CR32","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.rvsc.2019.09.013","volume":"135","author":"B Song","year":"2021","unstructured":"Song B, Zeng Q, Liu YWu B (2021) Effect of methionine deficiency on the apoptosis and cell cycle of kidney in broilers. Res Vet Sci 135:228\u2013236. https:\/\/doi.org\/10.1016\/j.rvsc.2019.09.013","journal-title":"Res Vet Sci"},{"key":"5447_CR33","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1096\/fj.201700419R","volume":"322","author":"D Cooke","year":"2018","unstructured":"Cooke D, Ouattara AAbles GP (2018) Dietary methionine restriction modulates renal response and attenuates kidney injury in mice. FASEB J 322:693\u2013702. https:\/\/doi.org\/10.1096\/fj.201700419R","journal-title":"FASEB J"},{"key":"5447_CR34","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2174\/0929867324666170509145240","volume":"253","author":"OSY Karmin","year":"2018","unstructured":"Karmin OSY (2018) Metabolic imbalance of homocysteine and hydrogen sulfide in kidney disease. Curr Med Chem 253:367\u2013377. https:\/\/doi.org\/10.2174\/0929867324666170509145240","journal-title":"Curr Med Chem"},{"key":"5447_CR35","doi-asserted-by":"publisher","unstructured":"Rinschen MM, Palygin O, El-Meanawy A, Domingo-Almenara X, Palermo A, Dissanayake LV, Golosova D, Schafroth MA, Guijas C, Demir F et al (2022) Accelerated lysine metabolism conveys kidney protection in salt-sensitive hypertension. Nat Commun 131. https:\/\/doi.org\/10.1038\/s41467-022-31670-0","DOI":"10.1038\/s41467-022-31670-0"},{"key":"5447_CR36","doi-asserted-by":"publisher","first-page":"F364","DOI":"10.1152\/ajprenal.00239.2022","volume":"3244","author":"RK Sharma","year":"2023","unstructured":"Sharma RK, Kamble SH, Krishnan S, Gomes J, To B, Li S, Liu IC, Gumz MLMohandas R (2023) Involvement of Lysyl oxidase in the pathogenesis of arterial stiffness in chronic kidney disease. Am J Physiology-Renal Physiol 3244:F364\u2013F373. https:\/\/doi.org\/10.1152\/ajprenal.00239.2022","journal-title":"Am J Physiology-Renal Physiol"},{"key":"5447_CR37","doi-asserted-by":"publisher","unstructured":"Razak MA, Begum PS, Viswanath B, Rajagopal SEssa MM (2017) Multifarious beneficial effect of nonessential amino Acid, glycine: A review. Oxidative Med Cell Longev 20171. https:\/\/doi.org\/10.1155\/2017\/1716701","DOI":"10.1155\/2017\/1716701"},{"key":"5447_CR38","doi-asserted-by":"publisher","first-page":"6824","DOI":"10.1002\/jcp.30370","volume":"23610","author":"Y Lan","year":"2021","unstructured":"Lan Y, Zhu W, Duan X, Deng T, Li S, Liu Y, Yang Z, Wen Y, Luo L, Zhao S et al (2021) Glycine suppresses kidney calcium oxalate crystal depositions via regulating urinary excretions of oxalate and citrate. J Cell Physiol 23610:6824\u20136835. https:\/\/doi.org\/10.1002\/jcp.30370","journal-title":"J Cell Physiol"},{"key":"5447_CR39","doi-asserted-by":"publisher","unstructured":"Hole\u010dek M (2024) Origin and roles of Alanine and glutamine in gluconeogenesis in the Liver, Kidneys, and small intestine under physiological and pathological conditions. Int J Mol Sci 2513. https:\/\/doi.org\/10.3390\/ijms25137037","DOI":"10.3390\/ijms25137037"},{"key":"5447_CR40","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/2211-5463.12862","volume":"106","author":"S Ichikawa","year":"2020","unstructured":"Ichikawa S, Gohda T, Murakoshi M, Li Z, Adachi E, Koshida TSuzuki Y (2020) Aspartic acid supplementation ameliorates symptoms of diabetic kidney disease in mice. FEBS Open Bio 106:1122\u20131134. https:\/\/doi.org\/10.1002\/2211-5463.12862","journal-title":"FEBS Open Bio"},{"key":"5447_CR41","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/jdi.13219","volume":"113","author":"K Kanasaki","year":"2020","unstructured":"Kanasaki K (2020) N-acetyl\u2010seryl\u2010aspartyl\u2010lysyl\u2010proline is a valuable endogenous antifibrotic peptide for kidney fibrosis in diabetes: an update and translational aspects. J Diabetes Invest 113:516\u2013526. https:\/\/doi.org\/10.1111\/jdi.13219","journal-title":"J Diabetes Invest"},{"key":"5447_CR42","doi-asserted-by":"publisher","unstructured":"Li H, Li S, Yang H, Wang Y, Wang JZheng N (2019) l-Proline alleviates kidney injury caused by AFB1 and AFM1 through regulating excessive apoptosis of kidney cells. https:\/\/doi.org\/10.3390\/toxins11040226. Toxins 114","DOI":"10.3390\/toxins11040226"},{"key":"5447_CR43","doi-asserted-by":"publisher","unstructured":"Aihara S, Torisu K, Uchida Y, Imazu N, Nakano TKitazono T (2023) Spermidine from arginine metabolism activates Nrf2 and inhibits kidney fibrosis. Commun Biology 61. https:\/\/doi.org\/10.1038\/s42003-023-05057-w","DOI":"10.1038\/s42003-023-05057-w"},{"key":"5447_CR44","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41581-021-00429-z","volume":"179","author":"M Carlstr\u00f6m","year":"2021","unstructured":"Carlstr\u00f6m M (2021) Nitric oxide signalling in kidney regulation and cardiometabolic health. Nat Rev Nephrol 179:575\u2013590. https:\/\/doi.org\/10.1038\/s41581-021-00429-z","journal-title":"Nat Rev Nephrol"},{"key":"5447_CR45","doi-asserted-by":"publisher","unstructured":"Baylis C (2008) Nitric oxide deficiency in chronic kidney disease. Am J Physiol Ren Physiol 2941. https:\/\/doi.org\/10.1152\/ajprenal.00424.2007. F1-9","DOI":"10.1152\/ajprenal.00424.2007"},{"key":"5447_CR46","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.niox.2009.12.002","volume":"222","author":"K Tsuchiya","year":"2010","unstructured":"Tsuchiya K, Tomita S, Ishizawa K, Abe S, Ikeda Y, Kihira YTamaki T (2010) Dietary nitrite ameliorates renal injury in L-NAME-induced hypertensive rats. Nitric Oxide 222:98\u2013103. https:\/\/doi.org\/10.1016\/j.niox.2009.12.002","journal-title":"Nitric Oxide"},{"key":"5447_CR47","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1093\/cvr\/cvq366","volume":"893","author":"M Carlstrom","year":"2011","unstructured":"Carlstrom M, Persson AE, Larsson E, Hezel M, Scheffer PG, Teerlink T, Weitzberg ELundberg JO (2011) Dietary nitrate attenuates oxidative stress, prevents cardiac and renal injuries, and reduces blood pressure in salt-induced hypertension. Cardiovasc Res 893:574\u2013585. https:\/\/doi.org\/10.1093\/cvr\/cvq366","journal-title":"Cardiovasc Res"},{"key":"5447_CR48","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.2215\/cjn.07400715","volume":"1012","author":"LL Hamm","year":"2015","unstructured":"Hamm LL, Nakhoul NHering-Smith KS (2015) Acid-Base homeostasis. Clin J Am Soc Nephrol 1012:2232\u20132242. https:\/\/doi.org\/10.2215\/cjn.07400715","journal-title":"Clin J Am Soc Nephrol"},{"key":"5447_CR49","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1046\/j.1523-1755.1999.055003778.x","volume":"553","author":"M Stumvoll","year":"1999","unstructured":"Stumvoll M, Perriello G, Meyer CGerich J (1999) Role of glutamine in human carbohydrate metabolism in kidney and other tissues. Kidney Int 553:778\u2013792. https:\/\/doi.org\/10.1046\/j.1523-1755.1999.055003778.x","journal-title":"Kidney Int"},{"key":"5447_CR50","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1177\/0148607112460682","volume":"375","author":"M Holecek","year":"2012","unstructured":"Holecek M (2012) Side effects of Long-Term glutamine supplementation. J Parenter Enter Nutr 375:607\u2013616. https:\/\/doi.org\/10.1177\/0148607112460682","journal-title":"J Parenter Enter Nutr"},{"key":"5447_CR51","doi-asserted-by":"publisher","unstructured":"Deng XTC, Fang T, Li T, Li X, Liu Y, Zhang X, Sun B, Sun H, Chen L (2025) Disruption of branched-chain amino acid homeostasis promotes the progression of DKD via enhancing inflammation and fibrosis-associated epithelial-mesenchymal transition. Metabolism 156037. https:\/\/doi.org\/10.1016\/j.metabol.2024.156037162","DOI":"10.1016\/j.metabol.2024.156037162"},{"key":"5447_CR52","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1097\/01.Asn.0000060574.38107.3b","volume":"145","author":"J-J Boffa","year":"2003","unstructured":"Boffa J-J, Lu Y, Placier S, Stefanski A, Dussaule J-CC C (2003) Regression of renal vascular and glomerular fibrosis. J Am Soc Nephrol 145:1132\u20131144. https:\/\/doi.org\/10.1097\/01.Asn.0000060574.38107.3b","journal-title":"J Am Soc Nephrol"},{"key":"5447_CR53","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jbior.2019.03.003","volume":"72","author":"M Jhanwar-Uniyal","year":"2019","unstructured":"Jhanwar-Uniyal M, Wainwright JV, Mohan AL, Tobias ME, Murali R, Gandhi CDSchmidt MH (2019) Diverse signaling mechanisms of mTOR complexes: mTORC1 and mTORC2 in forming a formidable relationship. Adv Biol Regul 72:51\u201362. https:\/\/doi.org\/10.1016\/j.jbior.2019.03.003","journal-title":"Adv Biol Regul"},{"key":"5447_CR54","doi-asserted-by":"publisher","unstructured":"Wang H, Liu Y, Wang D, Xu Y, Dong R, Yang Y, Lv Q, Chen XZhang Z (2019) The upstream pathway of mTOR-Mediated autophagy in liver diseases. Cells 812. https:\/\/doi.org\/10.3390\/cells8121597","DOI":"10.3390\/cells8121597"},{"key":"5447_CR55","doi-asserted-by":"publisher","unstructured":"Nobukuni T, Joaquin M, Roccio M, Dann SG, Kim SY, Gulati P, Byfield MP, Backer JM, Natt F, Bos JL et al (2005) Amino acids mediate mTOR raptor signaling through activation of class 3 phosphatidylinositol 3OH-kinase. Proc Natl Acad Sci U S A. 102: 14238\u201314243. https:\/\/doi.org\/10.1073\/pnas.0506925102","DOI":"10.1073\/pnas.0506925102"},{"key":"5447_CR56","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1042\/bj20061881","volume":"4031","author":"GM Findlay","year":"2007","unstructured":"Findlay GM, Yan L, Procter J, Mieulet VRFL (2007) A MAP4 kinase related to Ste20 is a nutrient-sensitive regulator of mTOR signalling. Biochem J 4031:13\u201320. https:\/\/doi.org\/10.1042\/bj20061881","journal-title":"Biochem J"},{"key":"5447_CR57","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cmet.2011.01.007","volume":"132","author":"S Kim","year":"2011","unstructured":"Kim S, Kim SF, Maag D, Maxwell MJ, Resnick AC, Juluri KR, Chakraborty A, Koldobskiy MA, Cha SH, Barrow R et al (2011) Amino acid signaling to mTOR mediated by inositol polyphosphate multikinase. Cell Metabol 132:215\u2013221. https:\/\/doi.org\/10.1016\/j.cmet.2011.01.007","journal-title":"Cell Metabol"},{"key":"5447_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/3693625","volume":"2018","author":"SD Viana","year":"2018","unstructured":"Viana SD, Reis FAlves R (2018) Therapeutic use of mTOR inhibitors in renal diseases: Advances, Drawbacks, and challenges. Oxidative Med Cell Longev 2018:1\u201317. https:\/\/doi.org\/10.1155\/2018\/3693625","journal-title":"Oxidative Med Cell Longev"},{"key":"5447_CR59","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.bbrc.2003.07.019","volume":"3132","author":"C Tokunaga","year":"2004","unstructured":"Tokunaga C, Yoshino KKS (2004) mTOR integrates amino acid- and energy-sensing pathways. Biochem Biophys Res Commun 3132:443\u2013446. https:\/\/doi.org\/10.1016\/j.bbrc.2003.07.019","journal-title":"Biochem Biophys Res Commun"},{"key":"5447_CR60","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1101\/gad.995802","volume":"1612","author":"DC Fingar","year":"2002","unstructured":"Fingar DC, Salama S, Tsou C, Harlow EBlenis J (2002) Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1\/eIF4E. Genes Dev 1612:1472\u20131487. https:\/\/doi.org\/10.1101\/gad.995802","journal-title":"Genes Dev"},{"key":"5447_CR61","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1210\/en.2002-220983","volume":"1444","author":"JA Bush","year":"2003","unstructured":"Bush JA, Kimball SR, O\u2019Connor PMJ, Suryawan A, Orellana RA, Nguyen HV, Jefferson LSDavis TA (2003) Translational control of protein synthesis in muscle and liver of growth Hormone-Treated pigs. Endocrinology 1444:1273\u20131283. https:\/\/doi.org\/10.1210\/en.2002-220983","journal-title":"Endocrinology"},{"key":"5447_CR62","doi-asserted-by":"publisher","unstructured":"Lamming DW, Cummings NE, Rastelli AL, Gao F, Cava E, Spelta BB, Pili F (2015) RL. F Restriction of dietary protein decreases mTORC1 in tumors and somatic tissues of a tumor-bearing mouse xenograft model. Oncotarget. 6: 31233\u201331240 https:\/\/doi.org\/10.1210\/en.2002-220983","DOI":"10.1210\/en.2002-220983"},{"key":"5447_CR63","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.cell.2009.01.021","volume":"1363","author":"MN Cohen AHall","year":"2009","unstructured":"Cohen AHall MN (2009) An amino acid shuffle activates mTORC1. Cell 1363:399\u2013400. https:\/\/doi.org\/10.1016\/j.cell.2009.01.021","journal-title":"Cell"},{"key":"5447_CR64","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1146\/annurev-immunol-020711-075049","volume":"33","author":"B Pulendran","year":"2015","unstructured":"Pulendran B (2015) The varieties of immunological experience: of Pathogens, Stress, and dendritic cells. Annu Rev Immunol 33:563\u2013606. https:\/\/doi.org\/10.1146\/annurev-immunol-020711-075049","journal-title":"Annu Rev Immunol"},{"key":"5447_CR65","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1042\/bst20211252","volume":"502","author":"GR Gold LTMasson","year":"2022","unstructured":"Gold LTMasson GR (2022) GCN2: roles in tumour development and progression. Biochem Soc Trans 502:737\u2013745. https:\/\/doi.org\/10.1042\/bst20211252","journal-title":"Biochem Soc Trans"},{"key":"5447_CR66","doi-asserted-by":"publisher","unstructured":"Shu S, Wang H, Zhu J, Fu Y, Cai J, Chen A, Tang CDong Z (2022) Endoplasmic reticulum stress contributes to cisplatin-induced chronic kidney disease via the PERK\u2013PKC\u03b4 pathway. Cell Mol Life Sci 798. https:\/\/doi.org\/10.1007\/s00018-022-04480-2","DOI":"10.1007\/s00018-022-04480-2"},{"key":"5447_CR67","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.1007\/s00018-012-1252-6","volume":"7019","author":"N Donnelly","year":"2013","unstructured":"Donnelly N, Gorman AM, Gupta SSamali A (2013) The eIF2\u03b1 kinases: their structures and functions. Cell Mol Life Sci 7019:3493\u20133511. https:\/\/doi.org\/10.1007\/s00018-012-1252-6","journal-title":"Cell Mol Life Sci"},{"key":"5447_CR68","doi-asserted-by":"publisher","first-page":"6909","DOI":"10.1093\/emboj\/20.23.6909","volume":"20","author":"AP Han","year":"2001","unstructured":"Han AP, Yu CN, Lu LR, Fujiwara Y, Browne C, Chin G, Fleming M, Leboulch P, H.Orkin S, JJ C (2001) Heme-regulated eIF2 kinase (HRI) is required for translational regulation and survival of erythroid precursors in iron deficiency. EMBO J 20:6909\u20136918. https:\/\/doi.org\/10.1093\/emboj\/20.23.6909","journal-title":"EMBO J"},{"key":"5447_CR69","doi-asserted-by":"publisher","first-page":"3094","DOI":"10.1111\/febs.15553","volume":"28810","author":"SE Girardin","year":"2020","unstructured":"Girardin SE, Cuziol C, Philpott DJArnoult D (2020) The eIF2\u03b1 kinase HRI in innate immunity, proteostasis, and mitochondrial stress. FEBS J 28810:3094\u20133107. https:\/\/doi.org\/10.1111\/febs.15553","journal-title":"FEBS J"},{"key":"5447_CR70","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1042\/bcj20160822","volume":"47412","author":"A Br\u00f6er SBr\u00f6er","year":"2017","unstructured":"Br\u00f6er SBr\u00f6er A (2017) Amino acid homeostasis and signalling in mammalian cells and organisms. Biochem J 47412:1935\u20131963. https:\/\/doi.org\/10.1042\/bcj20160822","journal-title":"Biochem J"},{"key":"5447_CR71","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1002\/iub.1090","volume":"6412","author":"R Murgu\u00eda JRSerrano","year":"2012","unstructured":"Murgu\u00eda JRSerrano R (2012) New functions of protein kinase Gcn2 in yeast and mammals. IUBMB Life 6412:971\u2013974. https:\/\/doi.org\/10.1002\/iub.1090","journal-title":"IUBMB Life"},{"key":"5447_CR72","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1016\/j.bbamcr.2014.04.006","volume":"18439","author":"BA Castilho","year":"2014","unstructured":"Castilho BA, Shanmugam R, Silva RC, Ramesh R, Himme BMSattlegger E (2014) Keeping the eIF2 alpha kinase Gcn2 in check. Biochimica et biophysica acta (BBA) -. Mol Cell Res 18439:1948\u20131968. https:\/\/doi.org\/10.1016\/j.bbamcr.2014.04.006","journal-title":"Mol Cell Res"},{"key":"5447_CR73","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1016\/j.biochi.2008.07.004","volume":"9011\u201312","author":"C Deval","year":"2008","unstructured":"Deval C, Talvas J, Chaveroux C, Maurin A-C, Mordier S, Cherasse Y, Parry L, Carraro V, Jousse C, Bruhat A et al (2008) Amino-acid limitation induces the GCN2 signaling pathway in myoblasts but not in myotubes. Biochimie 9011\u201312:1716\u20131721. https:\/\/doi.org\/10.1016\/j.biochi.2008.07.004","journal-title":"Biochimie"},{"issue":"5","key":"5447_CR74","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1080\/15548627.2016.1156823","volume":"12","author":"A Bretin","year":"2016","unstructured":"Bretin A, Carri\u00e8re J, Dalmasso G, Bergougnoux A, B\u2019chir W, Maurin AC, M\u00fcller S, Seibold F, Barnich N, Bruhat A et al (2016) Activation of the EIF2AK4-EIF2A\/eIF2\u03b1-ATF4 pathway triggers autophagy response to Crohn disease-associated adherent-invasive Escherichia coli infection. Autophagy 12(5):770\u2013783. https:\/\/doi.org\/10.1080\/15548627.2016.1156823","journal-title":"Autophagy"},{"issue":"6","key":"5447_CR75","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.celrep.2015.09.055","volume":"13","author":"ZA Leib DEKnight","year":"2015","unstructured":"Leib DEKnight ZA (2015) Re-examination of dietary amino acid sensing reveals a GCN2-Independent mechanism. Cell Rep 13(6):1081\u20131089. https:\/\/doi.org\/10.1016\/j.celrep.2015.09.055","journal-title":"Cell Rep"},{"key":"5447_CR76","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1007\/s00726-014-1835-7","volume":"4710","author":"CM Fader","year":"2014","unstructured":"Fader CM, Aguilera MOColombo MI (2014) Autophagy response: manipulating the mTOR-controlled machinery by amino acids and pathogens. Amino Acids 4710:2101\u20132112. https:\/\/doi.org\/10.1007\/s00726-014-1835-7","journal-title":"Amino Acids"},{"key":"5447_CR77","doi-asserted-by":"publisher","unstructured":"Kimball SRLSJ (2002) Control of protein synthesis by amino acid availability. Curr Opin Clin Nutr Metab Care. 5: 63\u201367. https:\/\/doi.org\/10.1097\/00075197-200201000-00012","DOI":"10.1097\/00075197-200201000-00012"},{"key":"5447_CR78","doi-asserted-by":"publisher","first-page":"E1313","DOI":"10.1152\/ajpendo.91000.2008","volume":"2976","author":"N Chotechuang","year":"2009","unstructured":"Chotechuang N, Azzout-Marniche D, Bos C, Chaumontet C, Gausser\u00e8s N, Steiler T, Gaudichon CTom\u00e9 D (2009) mTOR, AMPK, and GCN2 coordinate the adaptation of hepatic energy metabolic pathways in response to protein intake in the rat. Am J Physiology-Endocrinology Metabolism 2976:E1313\u2013E1323. https:\/\/doi.org\/10.1152\/ajpendo.91000.2008","journal-title":"Am J Physiology-Endocrinology Metabolism"},{"key":"5447_CR79","doi-asserted-by":"publisher","first-page":"10341","DOI":"10.1074\/jbc.M610631200","volume":"28214","author":"CE Gleason","year":"2007","unstructured":"Gleason CE, Lu DH, Witters LA, Newgard CBJ, Birnbaum M (2007) The role of AMPK and mTOR in nutrient sensing in pancreatic \u03b2-Cells. J Biol Chem 28214:10341\u201310351. https:\/\/doi.org\/10.1074\/jbc.M610631200","journal-title":"J Biol Chem"},{"issue":"7","key":"5447_CR80","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1093\/jn\/134.7.1704","volume":"134","author":"DR Bolster","year":"2004","unstructured":"Bolster DR, Vary TC, Kimball SRLSJ (2004) Leucine regulates translation initiation in rat skeletal muscle via enhanced eIF4G phosphorylation. J Nutr 134(7):1704\u20131710. https:\/\/doi.org\/10.1093\/jn\/134.7.1704","journal-title":"J Nutr"},{"key":"5447_CR81","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.cmet.2007.01.001","volume":"52","author":"DR Guo FCavener","year":"2007","unstructured":"Guo FCavener DR (2007) The GCN2 eIF2\u03b1 kinase regulates Fatty-Acid homeostasis in the liver during deprivation of an essential amino acid. Cell Metabol 52:103\u2013114. https:\/\/doi.org\/10.1016\/j.cmet.2007.01.001","journal-title":"Cell Metabol"},{"key":"5447_CR82","doi-asserted-by":"publisher","unstructured":"Costa-Mattioli MWalter P (2020) The integrated stress response: from mechanism to disease. Science 3686489. https:\/\/doi.org\/10.1126\/science.aat5314","DOI":"10.1126\/science.aat5314"},{"key":"5447_CR83","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/jcp.20272","volume":"2041","author":"C Fumarola","year":"2004","unstructured":"Fumarola C, Monica SLGuidotti GG (2004) Amino acid signaling through the mammalian target of Rapamycin (mTOR) pathway: role of glutamine and of cell shrinkage. J Cell Physiol 2041:155\u2013165. https:\/\/doi.org\/10.1002\/jcp.20272","journal-title":"J Cell Physiol"},{"key":"5447_CR84","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00726-008-0225-4","volume":"371","author":"Marc Rhoads JWu G","year":"2009","unstructured":"Marc Rhoads JWu G (2009) Glutamine, arginine, and leucine signaling in the intestine. Amino Acids 371:111\u2013122. https:\/\/doi.org\/10.1007\/s00726-008-0225-4","journal-title":"Amino Acids"},{"key":"5447_CR85","doi-asserted-by":"publisher","first-page":"3742","DOI":"10.1046\/j.1432-1033.2002.03069.x","volume":"26915","author":"U Krause","year":"2002","unstructured":"Krause U, Bertrand L, Maisin L, Rosa MHue L (2002) Signalling pathways and combinatory effects of insulin and amino acids in isolated rat hepatocytes. Eur J Biochem 26915:3742\u20133750. https:\/\/doi.org\/10.1046\/j.1432-1033.2002.03069.x","journal-title":"Eur J Biochem"},{"key":"5447_CR86","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1007\/s00726-012-1312-0","volume":"436","author":"M Chiu","year":"2012","unstructured":"Chiu M, Tardito S, Barilli A, Bianchi MG, Dall\u2019Asta VBussolati O (2012) Glutamine stimulates mTORC1 independent of the cell content of essential amino acids. Amino Acids 436:2561\u20132567. https:\/\/doi.org\/10.1007\/s00726-012-1312-0","journal-title":"Amino Acids"},{"key":"5447_CR87","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.bbrc.2004.11.015","volume":"3261","author":"T Nakajo","year":"2004","unstructured":"Nakajo T, Yamatsuji T, Ban H, Shigemitsu K, Haisa M, Motoki T, Noma K, Nobuhisa T, Matsuoka J, Gunduz M et al (2004) Glutamine is a key regulator for amino acid-controlled cell growth through the mTOR signaling pathway in rat intestinal epithelial cells. Biochem Biophys Res Commun 3261:174\u2013180. https:\/\/doi.org\/10.1016\/j.bbrc.2004.11.015","journal-title":"Biochem Biophys Res Commun"},{"key":"5447_CR88","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3945\/an.110.1008","volume":"11","author":"G Wu","year":"2010","unstructured":"Wu G (2010) Functional amino acids in Growth, Reproduction, and health. Adv Nutr 11:31\u201337. https:\/\/doi.org\/10.3945\/an.110.1008","journal-title":"Adv Nutr"},{"key":"5447_CR89","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3892\/ijmm.13.4.537","volume":"13","author":"H Ban","year":"2004","unstructured":"Ban H, Shigemitsu K, Yamatsuji T, Haisa M, Nakajo T, Takaoka M, Nobuhisa T, Gunduz M, Tanaka NY, N (2004) Arginine and leucine regulate p70 S6 kinase and 4E-BP1 in intestinal epithelial cells. Int J Mol Med 13:537\u2013543. https:\/\/doi.org\/10.3892\/ijmm.13.4.537","journal-title":"Int J Mol Med"},{"key":"5447_CR90","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1002\/1873-3468.13990","volume":"5953","author":"E Harjes","year":"2020","unstructured":"Harjes E, Jameson GB, Tu YH, Burr N, Loo TS, Goroncy AK, Edwards PJB, Harjes S, Munro B, G\u00f6bl C et al (2020) Experimentally based structural model of Yih1 provides insight into its function in controlling the key translational regulator Gcn2. FEBS Lett 5953:324\u2013340. https:\/\/doi.org\/10.1002\/1873-3468.13990","journal-title":"FEBS Lett"},{"issue":"1","key":"5447_CR91","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/j.1600-065X.2012.01149.x","volume":"249","author":"TL McGaha","year":"2012","unstructured":"McGaha TL, Huang L, Lemos H, Metz R, Mautino M, Prendergast G (2012) Amino acid catabolism: a pivotal regulator of innate and adaptive immunity. Immunol Rev 249(1):135\u2013157. https:\/\/doi.org\/10.1111\/j.1600-065X.2012.01149.x","journal-title":"Immunol Rev"},{"key":"5447_CR92","doi-asserted-by":"publisher","unstructured":"Tom\u00e9 D (2021) Amino acid metabolism and signalling pathways: potential targets in the control of infection and immunity. Nutr Diabetes 111. https:\/\/doi.org\/10.1038\/s41387-021-00164-1","DOI":"10.1038\/s41387-021-00164-1"},{"issue":"118","key":"5447_CR93","doi-asserted-by":"publisher","first-page":"118ra111","DOI":"10.1126\/scitranslmed.3002629","volume":"4","author":"W Peng","year":"2012","unstructured":"Peng W, Robertson L, Gallinetti J, Mejia P, Vose S, Charlip A, Chu TJRM (2012) Surgical stress resistance induced by single amino acid deprivation requires Gcn2 in mice. Sci Transl Med 4(118):118ra111. https:\/\/doi.org\/10.1126\/scitranslmed.3002629","journal-title":"Sci Transl Med"},{"key":"5447_CR94","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nature17186","volume":"5317595","author":"R Ravindran","year":"2016","unstructured":"Ravindran R, Loebbermann J, Nakaya HI, Khan N, Ma H, Gama L, Machiah DK, Lawson B, Hakimpour P, Wang Y-c et al (2016) The amino acid sensor GCN2 controls gut inflammation by inhibiting inflammasome activation. Nature 5317595:523\u2013527. https:\/\/doi.org\/10.1038\/nature17186","journal-title":"Nature"},{"key":"5447_CR95","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.expneurol.2018.12.004","volume":"313","author":"Z Lu","year":"2019","unstructured":"Lu Z, Wang Z, Yu L, Ding Y, Xu Y, Xu N, Li R, Tang J, Chen GZhang JH (2019) GCN2 reduces inflammation by p-eIF2\u03b1\/ATF4 pathway after intracerebral hemorrhage in mice. Exp Neurol 313:16\u201325. https:\/\/doi.org\/10.1016\/j.expneurol.2018.12.004","journal-title":"Exp Neurol"},{"key":"5447_CR96","doi-asserted-by":"publisher","unstructured":"Lin S, Ye MY, Fu QY, Pan CL, Liu YJ, Zheng LM, Hong QChen YH (2023) Cholic acid exposure during late pregnancy causes placental dysfunction and fetal growth restriction by reactive oxygen species-mediated activation of placental GCN2\/eIF2\u03b1 pathway. FASEB J 373. https:\/\/doi.org\/10.1096\/fj.202202126R","DOI":"10.1096\/fj.202202126R"},{"key":"5447_CR97","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.bbrc.2011.10.027","volume":"4151","author":"C Chaveroux","year":"2011","unstructured":"Chaveroux C, Lambert-Langlais S, Parry L, Carraro V, Jousse C, Maurin A-C, Bruhat A, Marceau G, Sapin V, Averous J et al (2011) Identification of GCN2 as new redox regulator for oxidative stress prevention in vivo. Biochem Biophys Res Commun 4151:120\u2013124. https:\/\/doi.org\/10.1016\/j.bbrc.2011.10.027","journal-title":"Biochem Biophys Res Commun"},{"key":"5447_CR98","doi-asserted-by":"publisher","unstructured":"Yuan J, Yu Z, Gao J, Luo K, Shen X, Cui BLu Z (2022) Inhibition of GCN2 alleviates hepatic steatosis and oxidative stress in obese mice: involvement of NRF2 regulation. Redox Biol 49. https:\/\/doi.org\/10.1016\/j.redox.2021.102224","DOI":"10.1016\/j.redox.2021.102224"},{"key":"5447_CR99","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.freeradbiomed.2018.10.445","volume":"130","author":"W Feng","year":"2019","unstructured":"Feng W, Lei T, Wang Y, Feng R, Yuan J, Shen X, Wu Y, Gao J, Ding WLu Z (2019) GCN2 deficiency ameliorates cardiac dysfunction in diabetic mice by reducing lipotoxicity and oxidative stress. Free Radic Biol Med 130:128\u2013139. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.10.445","journal-title":"Free Radic Biol Med"},{"key":"5447_CR100","doi-asserted-by":"publisher","first-page":"F180","DOI":"10.1152\/ajprenal.00015.2012","volume":"3032","author":"JS Lieberthal WLevine","year":"2012","unstructured":"Lieberthal WLevine JS (2012) Mammalian target of Rapamycin and the kidney. II. Pathophysiology and therapeutic implications. Am J Physiology-Renal Physiol 3032:F180\u2013F191. https:\/\/doi.org\/10.1152\/ajprenal.00015.2012","journal-title":"Am J Physiology-Renal Physiol"},{"key":"5447_CR101","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.bbrc.2020.09.120","volume":"5334","author":"K Kim","year":"2020","unstructured":"Kim K, Park JE, Yeom J, Park N, Tr\u1ea7n TXTKang MJ (2020) Tissue-specific roles of GCN2 in aging and autosomal dominant retinitis pigmentosa. Biochem Biophys Res Commun 5334:1054\u20131060. https:\/\/doi.org\/10.1016\/j.bbrc.2020.09.120","journal-title":"Biochem Biophys Res Commun"},{"key":"5447_CR102","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nrneph.2016.183","volume":"132","author":"I Sturmlechner","year":"2016","unstructured":"Sturmlechner I, Durik M, Sieben CJ, Baker DJvan Deursen JM (2016) Cellular senescence in renal ageing and disease. Nat Rev Nephrol 132:77\u201389. https:\/\/doi.org\/10.1038\/nrneph.2016.183","journal-title":"Nat Rev Nephrol"},{"key":"5447_CR103","doi-asserted-by":"publisher","unstructured":"Okada A, Nangaku M, Jao T-M, Maekawa H, Ishimono Y, Kawakami TInagi R (2017) D-serine, a novel uremic toxin, induces senescence in human renal tubular cells via GCN2 activation. Sci Rep 71. https:\/\/doi.org\/10.1038\/s41598-017-11049-8","DOI":"10.1038\/s41598-017-11049-8"},{"key":"5447_CR104","doi-asserted-by":"publisher","unstructured":"Wang J, Lv X, Lin Y, Aniwan A, Liu H, Zhou SYu P (2024) Genistein inhibits HIF-1\u03b1 and attenuates high glucose-induced peritoneal mesothelial-mesenchymal transition and fibrosis via the mTOR\/OGT pathway. https:\/\/doi.org\/10.1038\/s41598-024-74879-3. Scientific Reports 141","DOI":"10.1038\/s41598-024-74879-3"},{"key":"5447_CR105","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1016\/s0140-6736(16)00272-5","volume":"38710032","author":"K Floege JAmann","year":"2016","unstructured":"Floege JAmann K (2016) Primary glomerulonephritides. Lancet 38710032:2036\u20132048. https:\/\/doi.org\/10.1016\/s0140-6736(16)00272-5","journal-title":"Lancet"},{"key":"5447_CR106","doi-asserted-by":"publisher","unstructured":"Zhang G-X, Yang A-X, Zhang H-T, Sun Y-L, Luo R-R, Yang JZhou B-Y (2023) Dexmedetomidine alleviates Ischemia\/Reperfusion-Associated acute kidney injury by enhancing autophagic activity via the \u03b12-AR\/AMPK\/mTOR pathway. Front Bioscience-Landmark 2812. https:\/\/doi.org\/10.31083\/j.fbl2812323","DOI":"10.31083\/j.fbl2812323"},{"key":"5447_CR107","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.bbrc.2009.04.136","volume":"3844","author":"H Mori","year":"2009","unstructured":"Mori H, Inoki K, Masutani K, Wakabayashi Y, Komai K, Nakagawa R, Guan K-LYoshimura A (2009) The mTOR pathway is highly activated in diabetic nephropathy and Rapamycin has a strong therapeutic potential. Biochem Biophys Res Commun 3844:471\u2013475. https:\/\/doi.org\/10.1016\/j.bbrc.2009.04.136","journal-title":"Biochem Biophys Res Commun"},{"key":"5447_CR108","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1159\/000106782","volume":"275","author":"Y Yang","year":"2007","unstructured":"Yang Y, Wang J, Qin L, Shou Z, Zhao J, Wang H, Chen YChen J (2007) Rapamycin prevents early steps of the development of diabetic nephropathy in rats. Am J Nephrol 275:495\u2013502. https:\/\/doi.org\/10.1159\/000106782","journal-title":"Am J Nephrol"},{"key":"5447_CR109","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.7150\/thno.102559","volume":"156","author":"J Yang","year":"2025","unstructured":"Yang J, Yuan L, Li L, Liu F, Liu J, Chen Y, Fu P, Lu YYuan Y (2025) Trehalose activates autophagy to alleviate cisplatin-induced chronic kidney injury by targeting the mTOR-dependent TFEB signaling pathway. Theranostics 156:2544\u20132563. https:\/\/doi.org\/10.7150\/thno.102559","journal-title":"Theranostics"},{"key":"5447_CR110","doi-asserted-by":"publisher","unstructured":"Lin F, Liu Y, Tang L, Xu X, Zhang X, Song Y, Chen B, Ren YYang X (2021) Rapamycin protects against aristolochic acid nephropathy in mice by potentiating mammalian target of rapamycin\u2013mediated autophagy. Mol Med Rep 241. https:\/\/doi.org\/10.3892\/mmr.2021.12134","DOI":"10.3892\/mmr.2021.12134"},{"key":"5447_CR111","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1152\/physrev.00026.2020","volume":"1013","author":"AKE Szwed","year":"2021","unstructured":"Szwed AKE, Jacinto E (2021) Regulation and metabolic functions of mTORC1 and mTORC2. Physiol Rev 1013:1371\u20131426. https:\/\/doi.org\/10.1152\/physrev.00026.2020","journal-title":"Physiol Rev"},{"key":"5447_CR112","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.canlet.2017.08.038","volume":"408","author":"H Zeng","year":"2017","unstructured":"Zeng H (2017) mTOR signaling in immune cells and its implications for cancer immunotherapy. Cancer Lett 408:182\u2013189. https:\/\/doi.org\/10.1016\/j.canlet.2017.08.038","journal-title":"Cancer Lett"},{"key":"5447_CR113","doi-asserted-by":"publisher","unstructured":"Zhan Y, Zhu M, Liu S, Lu J, Ni Z, Cai HZhang W (2021) MicroRNA\u201393 inhibits the apoptosis and inflammatory response of tubular epithelial cells via the PTEN\/AKT\/mTOR pathway in acute kidney injury. Mol Med Rep 243. https:\/\/doi.org\/10.3892\/mmr.2021.12305","DOI":"10.3892\/mmr.2021.12305"},{"key":"5447_CR114","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1080\/15548627.2019.1628536","volume":"163","author":"Y-F Wu","year":"2019","unstructured":"Wu Y-F, Li Z-Y, Dong L-L, Li W-J, Wu Y-P, Wang J, Chen H-P, Liu H-W, Li M, Jin C-L et al (2019) Inactivation of MTOR promotes autophagy-mediated epithelial injury in particulate matter-induced airway inflammation. Autophagy 163:435\u2013450. https:\/\/doi.org\/10.1080\/15548627.2019.1628536","journal-title":"Autophagy"},{"key":"5447_CR115","doi-asserted-by":"publisher","unstructured":"Lin TA, Wu VCCYW (2019) Autophagy in chronic kidney diseases. Cells 81. https:\/\/doi.org\/10.3390\/cells8010061","DOI":"10.3390\/cells8010061"},{"key":"5447_CR116","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1007\/s11255-020-02545-4","volume":"529","author":"EAT Koch","year":"2020","unstructured":"Koch EAT, Nakhoul R, Nakhoul FNakhoul N (2020) Autophagy in diabetic nephropathy: a review. Int Urol Nephrol 529:1705\u20131712. https:\/\/doi.org\/10.1007\/s11255-020-02545-4","journal-title":"Int Urol Nephrol"},{"key":"5447_CR117","doi-asserted-by":"publisher","unstructured":"He L, Livingston MJDong Z (2014) Autophagy in acute kidney injury and Repair. Nephron clinical practice. 1271\u20134:56\u201360. https:\/\/doi.org\/10.1159\/000363677","DOI":"10.1159\/000363677"},{"key":"5447_CR118","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.febslet.2010.01.017","volume":"5847","author":"CH Jung","year":"2010","unstructured":"Jung CH, Ro SH, Cao J, Otto NMKim D-H (2010) mTOR regulation of autophagy. FEBS Lett 5847:1287\u20131295. https:\/\/doi.org\/10.1016\/j.febslet.2010.01.017","journal-title":"FEBS Lett"},{"key":"5447_CR119","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1242\/jcs.051011","volume":"12220","author":"DM Laplante MSabatini","year":"2009","unstructured":"Laplante MSabatini DM (2009) mTOR signaling at a glance. J Cell Sci 12220:3589\u20133594. https:\/\/doi.org\/10.1242\/jcs.051011","journal-title":"J Cell Sci"},{"key":"5447_CR120","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/978-981-15-0602-4_3","volume":"1206","author":"YHZ Wang","year":"2019","unstructured":"Wang YHZ (2019) Regulation of autophagy by mTOR signaling pathway. Adv Exp Med Biol 1206:67\u201383. https:\/\/doi.org\/10.1007\/978-981-15-0602-4_3","journal-title":"Adv Exp Med Biol"},{"key":"5447_CR121","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.semnephrol.2013.11.002","volume":"341","author":"K Inoki","year":"2014","unstructured":"Inoki K (2014) mTOR signaling in autophagy regulation in the kidney. Semin Nephrol 341:2\u20138. https:\/\/doi.org\/10.1016\/j.semnephrol.2013.11.002","journal-title":"Semin Nephrol"},{"key":"5447_CR122","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1007\/s11255-016-1398-5","volume":"4812","author":"S Liang","year":"2016","unstructured":"Liang S, Jin J, Gong J, Lin B, Li YHe Q (2016) How many podocyte autophagosomes are there in Immunoglobulin A nephropathy and idiopathic membranous nephropathy? Int Urol Nephrol 4812:2109\u20132114. https:\/\/doi.org\/10.1007\/s11255-016-1398-5","journal-title":"Int Urol Nephrol"},{"key":"5447_CR123","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/nep.13855","volume":"265","author":"R Luan","year":"2021","unstructured":"Luan R, Tian G, Ci X, Zheng Q, Wu LLu X (2021) Differential expression analysis of urinary Exosomal circular RNAs in patients with IgA nephropathy. Nephrology 265:432\u2013441. https:\/\/doi.org\/10.1111\/nep.13855","journal-title":"Nephrology"},{"key":"5447_CR124","doi-asserted-by":"publisher","unstructured":"Xu Y, Ling Y, Yang F, Deng J, Rong L, Jiang MJiang X (2017) The mTOR\/p70S6K1 signaling pathway in renal fibrosis of children with Immunoglobulin A nephropathy. J Renin-Angiotensin-Aldosterone Syst 183. https:\/\/doi.org\/10.1177\/1470320317717831","DOI":"10.1177\/1470320317717831"},{"key":"5447_CR125","doi-asserted-by":"publisher","unstructured":"Xia M, Liu D, Tang X, Liu Y, Liu H, Liu Y, Chen GLiu H (2020) Dihydroartemisinin inhibits the proliferation of IgAN mesangial cells through the mTOR signaling pathway. Int Immunopharmacol 80. https:\/\/doi.org\/10.1016\/j.intimp.2019.106125","DOI":"10.1016\/j.intimp.2019.106125"},{"key":"5447_CR126","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1681\/asn.2008040416","volume":"204","author":"E Burgess","year":"2009","unstructured":"Burgess E, Muirhead N, de Cotret PR, Chiu A, Pichette VTobe S (2009) Supramaximal dose of Candesartan in proteinuric renal disease. J Am Soc Nephrol 204:893\u2013900. https:\/\/doi.org\/10.1681\/asn.2008040416","journal-title":"J Am Soc Nephrol"},{"key":"5447_CR127","doi-asserted-by":"publisher","unstructured":"Shabaka A, Cases-Corona CFernandez-Juarez G (2021) Therapeutic insights in chronic kidney disease progression. Front Med 8. https:\/\/doi.org\/10.3389\/fmed.2021.645187","DOI":"10.3389\/fmed.2021.645187"},{"key":"5447_CR128","doi-asserted-by":"publisher","unstructured":"Remuzzi G, Hill NR, Fatoba ST, Oke JL, Hirst JA, O\u2019Callaghan CA, Lasserson DSHobbs FDR (2016) Global prevalence of chronic kidney Disease \u2013 A systematic review and Meta-Analysis. PLoS ONE 117. https:\/\/doi.org\/10.1371\/journal.pone.0158765","DOI":"10.1371\/journal.pone.0158765"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-025-05447-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-025-05447-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-025-05447-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T16:52:41Z","timestamp":1773766361000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-025-05447-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":128,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["5447"],"URL":"https:\/\/doi.org\/10.1007\/s11010-025-05447-0","relation":{},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"11 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}